Profile
Owen McCarth is the founder of MedRhythms, Inc. which was founded in 2013.
He held the title of President & Director.
Currently, he is the Chairman at Digital Therapeutics Alliance since 2022.
Mr. McCarth has an undergraduate degree from the University of Maine and an MBA from Harvard Business School.
Owen McCarth active positions
Companies | Position | Start |
---|---|---|
MedRhythms, Inc.
MedRhythms, Inc. Medical/Nursing ServicesHealth Services MedRhythms, Inc. is a digital therapeutics company based in Portland, ME. The company uses sensors, music, and software to develop evidence-based neurologic interventions to measure and improve walking. MedRhythms is dedicated to developing direct-stimulation digital therapeutics that provide direct stimulation to enable the mechanism of action in each relevant population. The company has an active pipeline of prescription digital therapeutics targeting rehabilitation and prevention in areas of neurologic injury and disease. The company's platform combines sensors, software, and music with advanced neuroscience to target neural circuitry. MedRhythms is on a mission to help people living with neurologic injuries and diseases optimize their health and independence through next-generation therapeutics to improve brain health. MedRhythms was founded in 2013 by Brian Harris and Owen McCarth, with Brian Harris serving as the CEO since then. | Founder | 01/01/2013 |
Digital Therapeutics Alliance
Digital Therapeutics Alliance Medical/Nursing ServicesHealth Services Digital Therapeutics Alliance is a non-profit trade association that serves as the leading authority on the evolution of digital health technology. The private company is based in Washington D.C., USA. The French company is dedicated to the understanding, adoption, and integration of digital therapeutics into healthcare. The company provides the digital health ecosystem with the necessary tools to define, evaluate, and utilize digital therapeutic products. The company works to enable expanded access to high quality, evidence-based digital therapeutics for patients, clinicians, and payors in order to improve clinical and health economic outcomes. | Chairman | 18/01/2022 |
Training of Owen McCarth
Harvard Business School | Masters Business Admin |
University of Maine | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
MedRhythms, Inc.
MedRhythms, Inc. Medical/Nursing ServicesHealth Services MedRhythms, Inc. is a digital therapeutics company based in Portland, ME. The company uses sensors, music, and software to develop evidence-based neurologic interventions to measure and improve walking. MedRhythms is dedicated to developing direct-stimulation digital therapeutics that provide direct stimulation to enable the mechanism of action in each relevant population. The company has an active pipeline of prescription digital therapeutics targeting rehabilitation and prevention in areas of neurologic injury and disease. The company's platform combines sensors, software, and music with advanced neuroscience to target neural circuitry. MedRhythms is on a mission to help people living with neurologic injuries and diseases optimize their health and independence through next-generation therapeutics to improve brain health. MedRhythms was founded in 2013 by Brian Harris and Owen McCarth, with Brian Harris serving as the CEO since then. | Health Services |
Digital Therapeutics Alliance
Digital Therapeutics Alliance Medical/Nursing ServicesHealth Services Digital Therapeutics Alliance is a non-profit trade association that serves as the leading authority on the evolution of digital health technology. The private company is based in Washington D.C., USA. The French company is dedicated to the understanding, adoption, and integration of digital therapeutics into healthcare. The company provides the digital health ecosystem with the necessary tools to define, evaluate, and utilize digital therapeutic products. The company works to enable expanded access to high quality, evidence-based digital therapeutics for patients, clinicians, and payors in order to improve clinical and health economic outcomes. | Health Services |
- Stock Market
- Insiders
- Owen McCarth